Stay updated on Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The record presents details for a completed Phase 2 trial evaluating sitravatinib in advanced liposarcoma and other soft tissue sarcomas, including participant criteria, study measures, and results-related information.
    Difference
    45%
    Check dated 2026-11-09T14:00:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The study-record page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:53:37.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates. It appears above the unchanged 403 Forbidden study record.
    Difference
    1%
    Check dated 2026-10-26T15:58:13.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2; the page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-19T20:51:18.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer’s site revision marker changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:08:04.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the expected content with an access-denied page. The page displays standard site chrome and a Home link, indicating restricted access to the study record.
    Difference
    0.5%
    Check dated 2026-09-28T20:54:09.000Z thumbnail image

Stay in the know with updates to Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Advanced Liposarcoma and Soft Tissue Sarcomas Clinical Trial page.